Skip Navigation
 
 
Printable Version

NADA Number: 110-048

Proprietary Name Valbazen®
Sponsor Pfizer, Inc.
Sponsor Address 235 East 42d St.
New York, NY    10017
USA
Ingredients Albendazole
Species Sheep, restricted during pregnancy
Cattle, beef
Cattle, dairy, excluding female breeding age animals
Cattle, restricted during pregnancy
Routes of Administration Per Os
Dose Form Liquid (suspension)
Drug Form Liquid (suspension)
Dispensing Status OTC
Exclusivity Seven year period of marketing exclusivity granted for the use of albendazole in the treatment of nonlactating goats for adult liver fluke (Fasciola hepatica).
Withdrawal Time Cattle: 27 days before slaughter Sheep: 7 days before slaughter Goats: 7 days before slaughter
Dosage Amount,
Indications
& Limitations

520.45a Albendazole suspension.

Specifications: The product contains 11.36 percent albendazole.

Conditions of use:

Cattle

Amount: 4.54 milligrams per pound of body weight (10 milligrams per kilogram). Administer as a single oral dose using dosing gun or dosing syringe.

Indications: For removal and control of the following internal parasites of cattle: adult liver flukes (Fasciola hepatica), heads and segments of tapeworms (Moniezia benedeni, M. expansa); adult and 4th stage larvae of stomach worms (brown stomach worms including 4th stage inhibited larvae (Ostertagia ostertagi), barberpole worm (Haemonchus contortus, H. placei), small stomach worm (Trichostrongylus axei)); adult and 4th stage larvae of intestinal worms (thread-necked intestinal worm (Nematodirus spathiger, N. helvetianus), small intestinal worm (Cooperia punctata and C. oncophora)); adult stages of intestinal worms (hookworm (Bunostomum phlebotomum) bankrupt worm (Trichostrongylus colubriformis), nodular worm (Oesophagostomum radiatum)); adult and 4th stage larvae of lungworms (Dictyocaulus viviparus).

Limitations: Do not use in female dairy cattle of breeding age: Do not administer to female cattle during first 45 days of pregnancy or for 45 days after removal of bulls.

Specifications: The product contains 4.55 or 11.36 percent albendazole.

Conditions of use:

Sheep

Amount: 3.4 mg/lb body weight (7.5 mg/kg) as a single oral dose using dosing gun or dosing syringe.

Indications for use: For removal and control of the following internal parasites of sheep: Adult liver flukes (Fasciola hepatica, Fascioloides magna); heads and segments of common tapeworms (Moniezia expansa) and fringed tapeworm (Thysanosoma actinoides); adult and fourth stage larvae of stomach worms (brown stomach worm (Ostertagia circumcincta and Marshallagia marshalli), barberpole worm (Haemonchus contortus), small stomach worm (Trichostrongylus axei)); adult and fourth stage larvae of intestinal worms (thread-necked intestinal worm (Nematodirus spathiger and N. filicollis), Cooper's worm (Cooperia oncophora), bankrupt worm (Trichostrongylus colubriformis), nodular worm (Oesophagostomum columbianum), and large-mouth bowel worm (Chabertia ovina)); adult and larval stages of lungworms (Dictyocaulus filaria).

Limitations: Do not slaughter within 7 days of last treatment. Do not administer to ewes during first 30 days of pregnancy or for 30 days after removal of rams.

Conditions of use:

Goats (non-lactating)

Amount: 4.54 mg/lb body weight (10 mg/kg) as a single oral dose using dosing gun or dosing syringe.

Indications for use: For the treatment of adult liver flukes (Fasciola hepatica) in nonlactating goats.

Limitations: Do not slaughter within 7 days of last treatment. Do not administer to does during first 30 days of pregnancy or for 30 days after removal of bucks.

Tolerances

Tolerances are established for residues of albendazole in uncooked edible tissues as follows:

a. In cattle: the tolerance for the 2-aminosulfone metabolite (marker residue) in liver (target tissue) is 0.2 part per million and in muscle 0.05 part per million.

b. In sheep: the tolerance for the 2-aminosulfone metabolite (marker residue) in liver (target tissue) is 0.25 part per million and in muscle of 0.05 part per million.